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Abstract
Objectives The aim was to index natural products for less
expensive preventive or curative anti-inflammatory thera-
peutic drugs.
Materials A set of 441 anti-inflammatory drugs repre-
senting the active domain and 2892 natural products
representing the inactive domain was used to construct a
predictive model for bioactivity-indexing purposes.
Method The model for indexing the natural products for
potential anti-inflammatory activity was constructed using
the iterative stochastic elimination algorithm (ISE). ISE is
capable of differentiating between active and inactive anti-
inflammatory molecules.
Results By applying the prediction model to a mix set of
(active/inactive) substances, we managed to capture 38%
of the anti-inflammatory drugs in the top 1% of the
screened set of chemicals, yielding enrichment factor of 38.
Ten natural products that scored highly as potential anti-
inflammatory drug candidates are disclosed. Searching the
PubMed revealed that only three molecules (Moupinamide,
Capsaicin, and Hypaphorine) out of the ten were tested and
reported as anti-inflammatory. The other seven phyto-
chemicals await evaluation for their anti-inflammatory
activity in wet lab.
Conclusion The proposed anti-inflammatory model can be
utilized for the virtual screening of large chemical data-
bases and for indexing natural products for potential anti-
inflammatory activity.
Keywords Anti-inflammatory  Chemoinformatics 
Ligand-based modeling  Bioactivity index
Introduction
Inflammation is critical for the development of many
complex diseases and disorders including autoimmune
diseases, metabolic syndrome, neurodegenerative diseases,
cancers, and cardiovascular diseases [1]. This warrants the
increasing interest in looking after anti-inflammatory
agents. Many original and review papers have reported the
inhibitory effect of plants and isolated natural products on
inflammation processes, at least in low-grade inflamma-
tion. These included natural polyphenols [2], resveratrol
[3], quercetin [4], lycopene [5], aspirin [6], edible plants
such as tomato [5], cactus [7], Citrus grandis [8], and
herbal medicine [9, 10]. In general, there is a strong public
need for natural [10, 11] and less expensive preventive and
curative anti-inflammatory therapeutics [12].
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Extended knowledge regarding inflammation will opti-
mize and hasten the development of innovative therapeutic
targets from natural sources, which can be used to manage
various chronic inflammation-related diseases. Computer
methodologies are utilized here, either to discover new hits
or to virtually screen large chemical databases [13–16].
There are two crucial components for constructing pre-
dictive models: an optimization method and databases of
active and inactive chemicals. Such models employ opti-
mization algorithms—for example, simulated annealing
[17], genetic algorithms [18, 19], neural networks [20, 21],
support vector machines [22, 23], the k-nearest neighbors
algorithm [24, 25], and combinations thereof [25–29].
These computerized techniques assume that the set of
active chemicals shares common features that are not easily
defined if only a narrow space from the active space is
utilized. Thus, using a large number of diverse active
molecules helps us draw significant and robust conclusions
concerning the properties of the active space. The inactive
chemicals should cover the property space of the virtually
screened database.
Over the last decade, we have developed a novel algo-
rithm, termed the iterative stochastic elimination (ISE)
algorithm, which is designed to scan a multi-dimensional
space and identify the best solutions (termed global and local
minima). It has been applied to solve bioinformatics prob-
lems—for example, positioning protons [30], predicting side
chains conformations [31], scanning the conformational
space of loops [32], and searching the conformational space
of cyclic peptides [33] and loops [34]. Later, it was tailored to
solve ligand-based problems, such as picking up discrimi-
native descriptors and optimizing the ranges of descriptors to
produce the best solutions for differentiating between active/
inactive objects. Models that can index chemicals for their
molecular bioactivity [25, 35, 36] and prioritize molecules in
large databases [36, 37] have also been constructed. It is
worth to assign that the anti-inflammatory drugs may act on
different biological targets via various mechanisms of action
[38, 39]. However, based on our previous experience [35],
the proposed filter-based indexing approach is a useful
technique capable to deal well with such complex problems.
Materials and methods
To construct a predictive model, we used a set of 441 anti-
inflammatory drugs [presented in SMILES format in the
supporting information (SI-Table 1)] to represent the active
domain and 2892 natural products to represent the inactive
domain. This natural product database was prepared by
collecting phytochemicals isolated from more than 800
different plants distributed worldwide and is available for
purchase from AnalytiCon Discovery (http://www.ac-
discovery.com). The diversity within the set of anti-in-
flammatory drugs is presented in Fig. 1a, and the diversity
within the set of natural products in Fig. 1b. The decision
to use a natural product database for the inactive domain is
justified, since prediction models utilized for virtual
screening should possess the same properties’ range as the
chemicals in the screened database, and this database was
prepared from phytochemicals isolated from plants.
The physico-chemical properties of all of the molecules
in both databases were identified with molecular operating
environment (MOE) software, version 2009.10. The one-
dimensional and two-dimensional descriptors were based
on calculated physico-chemical properties, such as
molecular weight, log P, H-bond donors, H-bond accep-
tors, solubility, total charge, charge distribution, type and
number of atoms, and so forth (http://www.chemcomp.
com/journal/descr.htm). For the validation and assessment
of the constructed model, the data sets of the active/inac-
tive chemicals were split into two-thirds for the training set
and one-third for the test set. The whole set was partitioned
into training and test sets with the use of a randomly
picking in-house module.
The model for indexing the natural products for poten-
tial anti-inflammatory activity was constructed with the
iterative stochastic elimination algorithm (ISE). With the
use of the ISE algorithm [35, 40] an optimal model capable
of differentiating between active and inactive molecules
could be attained with filters. The filters were constructed
by scanning the multivariable space to search for the best
sets of descriptors (‘‘variables’’) and the best range for each
descriptor that could differentiate between active and
inactive chemicals. Since descriptors typically interact with
each other, changes in the range of one descriptor can
affect the best range of another descriptor; therefore, to
detect the best set of filters, an optimization process should
take into consideration all descriptors of a certain set at the
same time. The main steps of the ISE-based modeling
process are shown schematically in Fig. 2. For further
details regarding ISE and its application for obtaining the
best ranges from a set of descriptors, and for the opti-
mization process, see our previous publications
[25, 36, 41]. The quality of the prediction model is eval-
uated by measuring various parameters such as enrichment
factor, Matthews correlation coefficient (MCC), ROC
curve and the area under ROC curve (AUC).
Results
The iterative stochastic elimination approach was
employed to commence an in silico prediction system
capable of indexing natural products for their anti-inflam-
matory bioactivity. This study is based on a set of 441 anti-
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inflammatory drugs, labeled as the active set, and 2892
natural products, labeled as the inactive set. It is worth
noting that a very small fraction of the natural products
labeled inactive could, in fact, be active, and the effect of
such an assumption on the quality of the prediction model
would be insignificant. For highly efficient virtual screen-
ing, we had to construct the prediction model using a set of
inactive chemicals that possess the same properties’ space
as those of the items in the screened database. As well,
aiming to assure that our active class was not biased by
similarities among structures, we checked for diversity
among the 441 anti-inflammatory drugs and the 2892 nat-
ural products and determined that they were very diverse.
More than 87% of the anti-inflammatory drugs had an
intermolecular Tanimoto index of similarity \ 0.7. As
shown in Fig. 3, more than 95% of the anti-inflammatory
drugs fall under Lipinski’s rule of 5 (ROF) [42], and 88%
fall under the Oprea rule for lead-likeness [43]. Figure 4
describes the distribution plots of a few of the physico-
chemical properties in the anti-inflammatory drugs’
database.
Discussion
Fifty-two unique filters (composed of different sets and
ranges of descriptors) were produced by applying the ISE
algorithm and then utilized to construct the anti-
Fig. 1 Diversity within anti-inflammatory drugs (a, left side) and natural products database (b, right side)
Fig. 2 Flowcharts of the modeling process (left side) and ISE engine (right side)
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inflammatory indexing model. Three of these efficient fil-
ters are described in Table 1. Filter number 1 in Table 1
has an MCC of 0.60, and it identified successfully nearly
92.95% of the anti-inflammatory drugs (true positives),
while only 35.34% of the natural product database was
misclassified (proposed as negatives but indexed by the
model as positives).
Analysis of the 52 filters in terms of their descriptors
revealed their discriminative physico-chemical properties/
descriptors. As shown in Table 2, the most dominant
descriptors in the best filters used to produce the anti-in-
flammatory indexing model include, among others, the
number of hydrogen bond donors, number of nitrogen
atoms, Lipinski druglike, log P [GCUT (0/3)], and frac-
tional positive VDW surface area. The number of
appearances of the descriptors shown in Table 2 was
4.5–25.9 times higher than expected in case of random
selection. Using the WORDLE module, we constructed
Fig. 5, which shows the redundancy of the descriptors in a
graphical manner. A full list of all the descriptors and their
Fig. 3 Physico-chemical properties’ distribution of the anti-inflam-
matory drugs: a molecular weight distribution, b log P values,
c number of H-bond acceptors [lip_acc], d number of H-bond donors
[lip_don], e number of rigid bonds, f number of rotatable bonds,
g number of aromatic atoms
Fig. 4 Violation distribution of anti-inflammatory drugs concerning Lipinski’s rules for drug-likeness and Oprea rules for lead-likeness
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redundancy is given in the supplemental information (SI-
Table 2).
The quality of the anti-inflammatory activity-indexing
model is described in Figs. 6, 7 and 8. The MBI thresholds
(x-axis) are plotted against the percentage of true/false
positives (left y-axis) and against the MCCs (right y-axis).
Figures 6 and 7 present the enrichment plot and the
receiver operating characteristic (ROC) plot of the pro-
posed anti-inflammatory activity-indexing model,
respectively. The enrichment plot (Fig. 7) demonstrates
how anti-inflammatory drug candidates can be identified if
natural products are ranked according to the model’s pre-
dictions, as opposed to random selection. Note that the
enrichment plot of the ISE-based model yields results very
close to those of the perfect model in the top fraction. This
indicates that the proposed model has a high prioritization
power. Using a mix ratio of 1:100 for active:inactive
compounds, the proposed model managed to capture 34.5%
of the anti-inflammatory drugs in the top 1% of the
screened compounds, compared to 100% in the perfect
model and 1% in the random model. This means that the
enrichment factor in the top percentile was greater than
34-fold.
In the region of MBI C 9.0, the ISE-based model and
the perfect model somehow overlap. This means that the
proposed model is highly efficient at classifying and
picking anti-inflammatory drug candidates from a large
pool of inactive natural products. The achieved area under
the curve (AUC) was 0.94, indicating a very good pre-
diction model. The database of natural products composed
of 2892 phytochemicals was virtually screened using the
proposed anti-inflammatory indexing model. We assume
Table 1 Ranges of descriptors and efficiency ratings for three of the 52 filters used to produce the anti-inflammatory indexing model
Filter 1a Filter 2 Filter 3
MCC = 0.601 MCC = 0.599 MCC = 0.596
TP = 92.95% TP = 62.27% TP = 60.68%
TN = 64.66% TN = 94.43% TN = 95.26%
chi0v_C (0. to 0.80) GCUT_PEOE_1 (-2.28 to -0.94) a_heavy (0. to 4.0)
PEOE_VSA ? 2 (0. to 1.0) GCUT_SLOGP_0 (0. to 2.97) GCUT_PEOE_0 (0. to 2.96)
PEOE_VSA_POS (0. to 30.95) PEOE_VSA_POS (0. to 41.27) GCUT_PEOE_1 (-2.28 to -0.94)
PC? (0. to 33.80) Diameter (0. to 78.12) PEOE_RPC (0. to 6.13)
The definition of the physico-chemical properties of the descriptors’ codes and the method, which was utilized by MOE software for their
calculation, could be found in http://www.cadaster.eu/sites/cadaster.eu/files/challenge/descr.htm
aThe filters could be composed of different sets of descriptors and/or ranges (potential lower limit/upper limit) for each descriptor
Table 2 Partial list of the redundancy of descriptors within the set of
52 filters that were used to construct the anti-inflammatory indexing
model
Descriptor name Number of
appearances
Dominant more
times than random
GCUT_SLOGP_0 29 25.9
a_don 17 15.2
a_nN 13 11.6
PEOE_VSA ? 4 13 11.6
PEOE_VSA_FPOS 9 8
BCUT_PEOE_3 8 7.2
SMR_VSA3 8 7.2
GCUT_PEOE_3 7 6.3
GCUT_SMR_3 6 5.4
GCUT_SLOGP_3 5 4.5
Lip_druglike 5 4.5
PEOE_VSA_FNEG 5 4.5
PEOE_VSA_FPPOS 5 4.5
Q_VSA_FPOS 5 4.5
SMR_VSA1 5 4.5
The full list of descriptors is given in the supplemental information
(SI-Table 2)
Fig. 5 Number of appearances
of descriptors in the 52 filters
used to produce the anti-
inflammatory indexing model.
The picture was constructed
using the WORDLE module
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that few chemicals in the database are anti-inflammatory
chemicals and will get high MBI score. The MBI score, as
shown in Fig. 6, ranges between -2.75 (lowest score) and
10.25 (highest score).
In Fig. 9, we disclose some of the natural products that
were highly indexed (MBI score above 8.0) as potential
anti-inflammatory drug candidates. Using threshold of MBI
8.0, the ratio of TP:FP is equal to 35:1. Searching the
PubMed revealed that only three molecules (Moupinamide,
Capsaicin, and Hypaphorine) out of the ten were tested and
reported as anti-inflammatory. Moupinamide (termed also
N-trans-feruloyltyramine) possesses anti-inflammatory
activity via suppression of mRNA expression of inducible
nitric oxide synthase [44] and inhibition of COX-I and
COX-II enzymes [45]. Capsaicin has shown efficacy in
treatment of pruritus [46], nonallergic rhinitis [47] (in-
flammation of the inner part of the nose) and H. pylori-
induced gastritis [48]. Few months ago, Sun et al. [49]
reported that hypaphorine counteracts inflammation via
inhibition of ERK or/and NFkB signaling pathways and
can be served as an anti-inflammatory candidate. The other
seven phytochemicals await evaluation for their anti-in-
flammatory activity in wet lab. One molecule
(Piperolactam A) from the untested set was reported as a
constituent [50] of Piper betle Linn that demonstrated anti-
inflammatory activity [51].
Conclusions
Using the iterative stochastic elimination algorithm, we
have built a highly discriminative and robust model cap-
able of indexing natural products for anti-inflammatory
bioactivity. We used a set of 441 anti-inflammatory drugs
to represent the active domain and 2892 natural products to
represent the inactive domain. The achieved area under the
curve (AUC) was 0.94, indicating a highly discriminative
and robust model. Some natural products that were scored
highly by our ISE-based anti-inflammatory indexing model
as anti-inflammatory drug candidates are disclosed. The
proposed anti-inflammatory model can be utilized for the
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virtual screening of large chemical databases and for
indexing natural products for potential anti-inflammatory
activity.
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